{
    "Trade/Device Name(s)": [
        "StatStrip Xpress Blood Glucose Monitoring System",
        "StatStrip Xpress Blood Glucose Monitor",
        "StatStrip Xpress Glucose Test Strips"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K170464",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160156"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "October 4, 2017",
    "Summary Letter Received Date": "October 5, 2017",
    "Submission Date": "November 3, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood (fingerstick)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "StatStrip Xpress Blood Glucose Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for StatStrip Xpress Blood Glucose Monitoring System for self-testing of blood glucose in capillary whole blood using an electrochemical biosensor.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertip for single-patient home use by people with diabetes as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}